Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 08-2025 | 08-2024 | 08-2023 | 08-2022 | 08-2021 | |
| Sales | 706 | 464 | 226 | 255 | 723 |
| Cost of Goods | 3 | 5 | 32 | 72 | 175 |
| Gross Profit | 703 | 460 | 195 | 184 | 547 |
| Operating Expenses | 12,587 | 6,217 | 6,760 | 6,874 | 6,410 |
| Operating Income | -11,881 | -5,753 | -6,534 | -6,619 | -5,687 |
| Other Income | -31 | -56 | -179 | -765 | 1,523 |
| Pre-tax Income | -11,911 | -5,809 | -6,713 | -7,384 | -4,164 |
| Net Income Continuous | -11,911 | -5,809 | -6,713 | -7,384 | -4,164 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | -22 |
| Minority Interests | -10 | -13 | -48 | -114 | -159 |
| Net Income | $-11,902 | $-5,795 | $-6,665 | $-7,269 | $-4,027 |
| EPS Basic Total Ops | -0.66 | -0.47 | -1.01 | -1.24 | -0.95 |
| EPS Basic Continuous Ops | -0.66 | -0.47 | -1.01 | -1.25 | -0.95 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | N/A | -0.01 |
| EPS Diluted Total Ops | -0.66 | -0.47 | -1.01 | -1.24 | -0.95 |
| EPS Diluted Continuous Ops | -0.66 | -0.47 | -1.01 | -1.25 | -0.95 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | N/A | -0.01 |
| EPS Diluted Before Non-Recurring Items | -0.66 | -0.47 | -1.01 | -1.24 | -0.95 |
| EBITDA(a) | $-11,793 | $-5,677 | $-6,389 | $-6,516 | $-5,539 |